News
Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...
“There continues to be strong interest in the potential of ITK inhibition to provide a new approach to treating a broad range of diseases, including immune mediated fibrotic diseases such as systemic ...
“There continues to be strong interest in the potential of ITK inhibition to provide a new approach to treating a broad range of diseases, including immune mediated fibrotic diseases such as ...
The chairman of the Board of Dangote Sugar Refinery Plc, Aliko Dangote, has announced his retirement, bringing an end to a 20-year leadership of the company. In a statement released by Company ...
I'm adding to my Amcor PLC position as financial results remain solid and shares are attractively priced, offering a strong risk premium over Treasuries. Despite a slight revenue decline ...
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of cancer and immune diseases.
Communities who may have once had reasons to take issue with the British crown now regard the King's visit as a moment to show solidarity, as ITV News' Royal Editor Chris Ship reports King Charles ...
Tahilyani will join UK-based asset management firm Prudential Plc as the regional CEO for India, Africa, Cambodia, Laos, and Myanmar, with additional responsibility of the health vertical ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results